Wednesday, November 30, 2011 11:10:17 AM
...lol...Dew, I won't bring up how both your extraordinary, RMF and personal assurance, completely blew the FDA Ampha approval which wiped out near 50% of Shareholder's equity.
Talk about banal.
...and speaking of the FDA NVS/Sandoz/MNTA M copax delayed approval...
anyone consider it is in NVS/Sandoz interests to delay it if they are, at some point looking to buy out MNTA?
Only $$$ Billions are at stake.
...Dew, btw, I am posting this on YMB and copying it for IHub monitors as you are notorious for deleting posts.
You already monitor Bio Tech Values...so you monitoring the MNTA board is not required.
y3
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM